Bristol Myers Squibb has served as a strategic partner for the Cancer Research Institute by providing unparalleled support to advance scientific research and educate patients about immunotherapy.
Their collaboration has supported the first online patient portal focused on immunotherapy (TheAnswerToCancer.org), multi-year title sponsorship of the Answer to Cancer cycling events, Cancer Immunotherapy and You webinar series, and Immunotherapy Patient Summit series, including the Inaugural Patient Summit. Bristol Myers Squibb has also supported the CRI Irvington Postdoctoral Fellowship Program, and the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.
In 2014, Bristol Myers Squibb’s leadership in the field of cancer immunotherapy was recognized with the Cancer Research Institute Oliver R. Grace Award, presented to Murdo Gordon, executive vice president and chief commercial officer, at the Cancer Research Institute Annual Awards Dinner.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This July for Sarcoma Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to sarcoma.
CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with a rare type of sarcoma.